Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00316-4/fulltext?dgcid=hubspot_email_conferencealerts_sccm24&utm_campaign=conferencealerts&utm_medium=email&_hsmi=290943338&_hsenc=p2ANqtz-9Ce-d2O9rWAnSs4FygvCdYhoxfmYkM9jl_AdzL5gcsfE0Rj2psGHq_UTBwH_xM44JXdVd0QdRZ-c6VdtLNp2nPkE3Oig&utm_content=290943338&utm_source=hs_email